Ratings by Lucid Capital Markets (Dev Prasad)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/24/2026 | Turn Therapeutics | TTRX | New Coverage | Buy (N/A) |
13.51 (10.57) |
-21.76% | Details | |
| 9/14/2026 | Faeth Therapeutics | FTH | New Coverage | Buy (N/A) |
37.44 (18.80) |
-49.79% | Details | |
| 9/8/2026 | Adlai Nortye Ltd. | ANL | New Coverage | Buy (N/A) |
15.01 (11.03) |
-26.52% | Details | |
| 8/20/2026 | Eloxx Pharma | ELOX | New Coverage | Buy (N/A) |
18.16 (13.03) |
-28.25% | Details | |
| 7/27/2026 | Polaryx Therapeutics | PLYX | New Coverage | Buy (N/A) |
2.05 (1.88) |
-8.29% | Details | |
| 5/4/2026 | Quoin Pharmaceuticals | QNRX | New Coverage | Buy (N/A) |
6.21 (3.90) |
-37.2% | Details | |
| 2/24/2026 | Palvella Therapeutics | PVLA | Maintain | Buy (N/A) |
|
Details | ||
| 12/15/2025 | Palvella Therapeutics | PVLA | Maintain | Buy (N/A) |
|
Details | ||
| 12/3/2025 | Palatin Technologies | PTN | New Coverage | Buy (N/A) |
19.63 (6.02) |
-69.33% | Details | |
| 11/5/2025 | Verrica Pharmaceuticals | VRCA | New Coverage | Buy (N/A) |
3.28 (3.60) |
9.76% | Details | |
| 9/15/2025 | aTyr Pharma | ATYR | Downgrade | Neutral (Buy) |
6.03 (0.17) |
-97.18% | Details | |
| 8/25/2025 | Cue Biopharma | CUE | New Coverage | Buy (N/A) |
0.83 (16.71) |
1913.25% | Details | |
| 6/17/2025 | Opus Genetics | IRD | New Coverage | Buy (N/A) |
0.94 (3.84) |
308.51% | Details | |
| 5/23/2025 | Edesa Biotech Inc. | EDSA | New Coverage | Buy (N/A) |
2.01 (2.57) |
27.86% | Details | |
| 3/18/2025 | Palvella Therapeutics | PVLA | New Coverage | Buy (N/A) |
27.50 (120.30) |
337.45% | Details | |
| 12/17/2024 | Avalo Therapeutics Inc. | AVTX | New Coverage | Buy (N/A) |
9.42 (11.27) |
19.64% | Details | |
| 12/17/2024 | iBio, Inc. | IBIO | New Coverage | Buy (N/A) |
2.35 (0.77) |
-67.23% | Details | |
| 12/17/2024 | CalciMedica | CALC | New Coverage | Buy (N/A) |
2.81 (1.04) |
-62.99% | Details | |
| 11/19/2024 | Inflarx NV | IFRX | New Coverage | Buy (N/A) |
1.74 (1.32) |
-24.14% | Details | |
| 11/19/2024 | aTyr Pharma | ATYR | New Coverage | Buy (N/A) |
3.01 (6.03) |
100.33% | Details |
